First AD

Second AD

The expert panel recaps and synthesizes key points and conclusions from each presentation and discussion over the course of the program.

OncLive Peer Exchange on Allo-HSCT: Conclusion of Discussion

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Optimizing Outcomes in Allogeneic Transplants

Peer Exchange

Memorial Sloan Kettering Cancer Center 

Cancer Centers

Partner

Moffitt Cancer Center

City of Hope

Role of Allogeneic Transplants in Hematologic Malignancies

Hematologic Malignancies and Transplant Options and Conditioning Regimens Used in Allo-HSCT

Supportive Care Measures for Patients Planning to Receive an Allogenic Transplant

Transplant Complications and Survival Outcomes

Clinical Trial Update: CTN Trial

Graft-versus-Host Disease Prophylaxis and Management

Patient Case Studies of GvHD

Emerging Cellular Therapies in Hematologic Malignancies

Transplant in the Elderly Population

Toxicity Assessment of Precision-Engineered Allo-HSCT

The Role of Allo-HSCT in Higher-Risk MDS

Investigational Allo-HSCT for Advanced Hematologic Malignancies

The Future of Allo-HSCT and Cellular Therapies